ArticleCell reports2023

Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4/6 inhibitors in breast cancer.

Sungsoo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.